NO954878L - Pyrrolderivater - Google Patents

Pyrrolderivater

Info

Publication number
NO954878L
NO954878L NO954878A NO954878A NO954878L NO 954878 L NO954878 L NO 954878L NO 954878 A NO954878 A NO 954878A NO 954878 A NO954878 A NO 954878A NO 954878 L NO954878 L NO 954878L
Authority
NO
Norway
Prior art keywords
compounds
pyrrole
inflammation
pain
useful
Prior art date
Application number
NO954878A
Other languages
English (en)
Other versions
NO954878D0 (no
Inventor
Jim W Barnett
James P Dunn
Denis J Kertesz
Aaron B Miller
Jr David John Morgans
Chakk S Ramesha
C Elliott Sigal
Eric Brian Sjogren
David B Smith
Francisco X Talamas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO954878D0 publication Critical patent/NO954878D0/no
Publication of NO954878L publication Critical patent/NO954878L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Det beskrives pyrrolderivater. Disse forbindelsene er anvendelige som antiinflammatoriske midler ved behandlingen av inflammasjon og smerte. Fremstillingen av disse forbindelsene, deres farmasøytisk akseptable salter samt farmasøytiske blandinger hvor disse forbindelsene inngår, er også beskrevet.
NO954878A 1994-12-01 1995-11-30 Pyrrolderivater NO954878L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/347,915 US5622948A (en) 1994-12-01 1994-12-01 Pyrrole pyridazine and pyridazinone anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO954878D0 NO954878D0 (no) 1995-11-30
NO954878L true NO954878L (no) 1996-06-03

Family

ID=23365840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954878A NO954878L (no) 1994-12-01 1995-11-30 Pyrrolderivater

Country Status (19)

Country Link
US (1) US5622948A (no)
EP (1) EP0714895A1 (no)
JP (1) JPH08208639A (no)
KR (1) KR960022506A (no)
CN (1) CN1066726C (no)
AR (1) AR001771A1 (no)
AU (1) AU3906295A (no)
BR (1) BR9505610A (no)
CA (1) CA2163490A1 (no)
CO (1) CO4650183A1 (no)
CZ (1) CZ316995A3 (no)
FI (1) FI955783A7 (no)
HU (1) HUT75117A (no)
IL (1) IL116139A0 (no)
MA (1) MA23735A1 (no)
NO (1) NO954878L (no)
PL (1) PL311536A1 (no)
TR (1) TR199501528A1 (no)
ZA (1) ZA9510027B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
DE69716061T2 (de) * 1996-05-30 2003-08-14 F. Hoffmann-La Roche Ag, Basel Pyrrolderivate
CA2205757C (en) * 1996-05-30 2006-01-24 F. Hoffmann-La Roche Ag Pyridazinone derivatives and their use as inhibitors of prostaglandin g/h synthase i and ii(cox i and ii)
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
EP1007515A1 (en) * 1997-08-22 2000-06-14 Abbott Laboratories Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors
US6525053B1 (en) 1997-08-22 2003-02-25 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
JP2003516925A (ja) * 1997-08-22 2003-05-20 アボット・ラボラトリーズ プロスタグランジンエンドペルオキシドｈシンターゼ生合成阻害剤としてのアリールピリダジノン
BR9812772A (pt) * 1997-10-27 2000-10-10 Reddy Research Foundation "compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
PL198503B1 (pl) * 1998-10-27 2008-06-30 Abbott Lab Związki pirydazynonowe, kompozycje farmaceutyczne je zawierające oraz ich zastosowanie
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
JP2005536507A (ja) * 2002-07-11 2005-12-02 メルク　エンド　カムパニー　インコーポレーテッド ６Ｈ−ピロロ［３，４−ｄ］ピリダジン化合物による神経障害性疼痛の治療
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
GB0610680D0 (en) 2006-05-31 2006-07-12 Istituto Di Ricerche D Biolog Therapeutic compounds
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
JP5758630B2 (ja) * 2007-11-15 2015-08-05 エンメエッセディ・イタリア・エッセ・エッレ・エッレ Ｐａｒｐ阻害剤としてのピリダジノン誘導体
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
EP2527335B1 (en) 2011-04-26 2013-09-18 King Saud University Triazole compounds as anti-inflammatory agents
KR102233456B1 (ko) 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
WO2022159980A1 (en) * 2021-01-25 2022-07-28 Athos Therapeutics, Inc. Pharmaceutical compounds and methods of making and using the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2316942A (en) * 1937-12-27 1943-04-20 Schlumberger Well Surv Corp Apparatus for measuring temperatures in boreholes
US3586681A (en) * 1967-11-02 1971-06-22 Sandoz Ag 1,4,5,6-tetrahydropyridazines
US3726978A (en) * 1967-11-02 1973-04-10 Sandoz Ag Tetrahydropyridazines and pyridazinones as anti-inflammatory agents
US3752826A (en) * 1970-01-26 1973-08-14 Mcneilab Inc Aroyl substituted pyrroles
US4048191A (en) * 1975-06-27 1977-09-13 Mcneil Laboratories, Incorporated Halo-substituted 1-loweralkyl-5-aroylpyrrole-2-acetic acid compounds
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4247551A (en) * 1979-09-17 1981-01-27 Gruppo Lepetit S.P.A. N-Pyrrolyl-pyridazineamines and their use as antihypertensive agents
US4347187A (en) * 1980-10-20 1982-08-31 Syntex (U.S.A.) Inc. Process for preparing 5-aroyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
IT1150070B (it) * 1980-12-22 1986-12-10 Lepetit Spa Procedimento per preparare derivati n-pirrolipiridazinamminici
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
EP0088128A4 (en) * 1981-09-11 1984-04-06 Diamond Shamrock Corp ANTI-IGNITION AND ANALGETIC 4-PYRIDYLPYRIDAZINE (2H) -3-ONE.
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
GB8501372D0 (en) * 1985-01-18 1985-02-20 Smith Kline French Lab Chemical compounds
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US4992441A (en) * 1987-10-14 1991-02-12 Mcneilab, Inc. 1-[[5-[[4-substituted-1-piperazinyl]methyl]-pyrrol-2-yl or furan-2-yl]methyl-2-piperidinones useful in treating schizophrenia
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
AU688282B2 (en) * 1992-09-22 1998-03-12 University Of Rochester Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
US5332736A (en) * 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5622948A (en) * 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
KR102081455B1 (ko) * 2017-06-09 2020-04-28 선상규 다중브러시를 이용한 직류발전장치

Also Published As

Publication number Publication date
HUT75117A (en) 1997-04-28
CN1132206A (zh) 1996-10-02
CZ316995A3 (en) 1996-06-12
NO954878D0 (no) 1995-11-30
AR001771A1 (es) 1997-12-10
CA2163490A1 (en) 1996-06-02
EP0714895A1 (en) 1996-06-05
US5622948A (en) 1997-04-22
HU9503384D0 (en) 1996-01-29
BR9505610A (pt) 1997-09-16
FI955783L (fi) 1996-06-02
PL311536A1 (en) 1996-06-10
CO4650183A1 (es) 1998-09-03
TR199501528A1 (tr) 1996-11-21
AU3906295A (en) 1996-06-06
CN1066726C (zh) 2001-06-06
JPH08208639A (ja) 1996-08-13
FI955783A0 (fi) 1995-12-01
MA23735A1 (fr) 1996-07-01
KR960022506A (ko) 1996-07-18
ZA9510027B (en) 1996-06-03
IL116139A0 (en) 1996-01-31
FI955783A7 (fi) 1996-06-02

Similar Documents

Publication Publication Date Title
MY119403A (en) Novel compounds with analgesic effect.
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
HUP9901807A3 (en) Heterocycle substituted n-acyl benzenesulfonamide derivatives, process for their preparation and their use as prodrug for the preparation of pharmaceutical compositions treating inflammation or inflammation-associated disorders
MY115662A (en) Novel compounds with analgesic effect
AU2740797A (en) Androstene derivatives
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
SE9900961D0 (sv) Novel compounds
NO984290L (no) Farmas°ytisk nyttige forbindelser
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
SE9802208D0 (sv) Novel compounds
NO983530L (no) Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
AU4830097A (en) Use of an extract of Cimicifuga
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
SE9802209D0 (sv) Novel compounds
SE9504662D0 (sv) New compounds
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
YU46302A (sh) Supstituisani piroli
WO2000002877A3 (en) New pharmaceutically active compounds
NO20001846L (no) Nye farmasøytisk aktive forbindelser, deres fremstilling og anvendelse som ECE-inhibitorer
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi